More than $200 billion in Covid loans potentially stolen by fraudsters, watchdog says

[ad_1] (L-R) Kevin Chambers, Director for COVID-19 Fraud Enforcement, Department of Justice; Hannibal “Mike” Ware, Inspector General, Small Business Administration; Michael Horowitz, Chair, Pandemic Response Accountability Committee; and Roy D. Dotson Jr., Acting Special Agent in Charge, National Pandemic Fraud Recovery Coordinator, United States Secret Service; testify during a hybrid hearing held by the House…

Read More

Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court

[ad_1] Chief Executive Officers of pharmaceutical companies testify before the Senate Finance Committee on “Drug Pricing in America: A Prescription for Change, Part II” February 26, 2019 in Washington, DC. From left to right are Richard A. Gonzalez, chairman and CEO of AbbVie Inc; Pascal Soriot, executive director and CEO of AstraZeneca; Giovanni Caforio, chairman…

Read More

Biden to appoint Mandy Cohen to lead the CDC

[ad_1] Dr. Mandy Cohen speaks at a news conference at the Emergency Operations Center in Raleigh, North Carolina, Nov. 10, 2021. Bryan Anderson | AP President Joe Biden on Friday said he will appoint Dr. Mandy Cohen to lead the Centers for Disease Control and Prevention. Cohen served as the head of North Carolina’s Department…

Read More

House Democrats press Walmart, Costco, Kroger to sell abortion pill mifepristone

[ad_1] In this photo illustration, packages of Mifepristone tablets are displayed at a family planning clinic on April 13, 2023 in Rockville, Maryland.  Anna Moneymaker | Getty Images House Democrats on Thursday called on Walmart, Costco, Kroger, Safeway and Health Mart to publicly commit to sell the prescription abortion pill mifepristone at their retail pharmacies….

Read More

FDA advisors recommend AstraZeneca, Sanofi antibody to protect babies from RSV

[ad_1] A panel of independent advisors to the Food and Drug Administration unanimously recommended Thursday that the antibody nirsevimab be approved for use to protect infants from respiratory syncytial virus, the leading cause of hospitalization among newborns. If the FDA approves nirsevimab, the antibody would become the first medical intervention available in the U.S. that…

Read More